B Merola

Author PubWeight™ 41.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 1997 2.14
2 Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 1998 1.58
3 Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J 1997 1.43
4 CV 205-502 treatment in therapy-resistant acromegalic patients. Eur J Endocrinol 1995 1.40
5 Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol 1996 1.39
6 Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) 1997 1.25
7 Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 1997 0.95
8 Acromegaly. J Clin Endocrinol Metab 1997 0.93
9 [Usefulness of color echo Doppler with power Doppler in the diagnosis of hypoechoic thyroid nodules: work in progress]. Radiol Med 1996 0.92
10 Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 1997 0.90
11 Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur J Endocrinol 1998 0.90
12 Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf) 1998 0.89
13 Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 1997 0.88
14 Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol 1997 0.87
15 Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol 1994 0.87
16 Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 1988 0.87
17 Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Clin Endocrinol (Oxf) 1998 0.85
18 Prediction of efficacy of octreotide therapy in patients with acromegaly. J Clin Endocrinol Metab 1996 0.85
19 Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001 0.84
20 Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 1998 0.80
21 Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas. Eur J Endocrinol 1995 0.79
22 Beta-endorphin concentrations both in plasma and in cerebrospinal fluid in response to acute painful stimuli. J Neurosurg Sci 1991 0.79
23 Cardiological aspects of growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 1998 0.78
24 Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood. J Clin Endocrinol Metab 1996 0.78
25 Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypophyseal phlebography. Neuroendocrinology 1987 0.78
26 Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR). Clin Endocrinol (Oxf) 1990 0.78
27 Failure of long-term therapy with sodium valproate in Cushing's disease. J Endocrinol Invest 1997 0.77
28 Headache and memory impairment. Study on 100 headache patients. Acta Neurol (Napoli) 1993 0.77
29 Effect of growth hormone on cardiac function. Horm Res 1997 0.77
30 The use of intercavernous sinuses phlebography in the diagnosis of ACTH-secreting microadenomas. World J Surg 1988 0.77
31 Short stature and azoospermia in a patient with Y chromosome long arm deletion. J Endocrinol Invest 1997 0.77
32 [Antiemetic effect of the levo isomer of sulpiride (L-sulpiride) in humans]. Minerva Anestesiol 1989 0.77
33 Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiography. Eur J Nucl Med 1996 0.77
34 Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome. World J Surg 1995 0.77
35 Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism. Neuroendocrinology 1986 0.77
36 Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas. J Endocrinol Invest 1988 0.77
37 Cardiovascular aspects in acromegaly: effects of treatment. Metabolism 1996 0.77
38 Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 1993 0.77
39 Hypothalamus-pituitary-adrenal (HPA) axis in physiological and pathological aging brain. Acta Neurol (Napoli) 1991 0.76
40 Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994 0.76
41 Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas. Eur J Endocrinol 1995 0.76
42 Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. J Endocrinol Invest 1999 0.75
43 Prolactin in inferior petrosal sinuses. Lancet 1990 0.75
44 Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases. J Endocrinol Invest 1992 0.75
45 Bone mineral density and circulating cytokines in patients with acromegaly. J Endocrinol Invest 1998 0.75
46 Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test. Horm Res 1993 0.75
47 Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas. Horm Res 1995 0.75
48 Hyperthyroidism due to a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma associated with functional hyperprolactinaemia. A case report. Acta Endocrinol (Copenh) 1987 0.75
49 [Treatment of early postoperative hypotonic polyuria in pituitary surgery]. Minerva Anestesiol 1986 0.75
50 Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects. J Endocrinol Invest 1997 0.75
51 [Anesthesiologic problems in transsphenoidal surgery of GH-secreting and ACTH-secreting adenomas]. Minerva Anestesiol 1986 0.75
52 Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD). J Clin Endocrinol Metab 1995 0.75
53 Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease. Horm Res 1996 0.75
54 Langerhans cell histiocytosis, diabetes insipidus, hyperprolactinemia and empty sella: a four-fold association. Report of two cases. J Endocrinol Invest 1996 0.75
55 Allergy to ergot-derived dopamine agonists. Lancet 1992 0.75
56 Pituitary hormones evaluation by means of selective venous sampling during phlebography of the cavernous sinuses: preliminary report on thirty four patients. Ann Radiol (Paris) 1984 0.75
57 [Cerebellar ataxia and hypogonadism. Description of 4 cases]. Riv Neurol 1988 0.75
58 [Trans-sphenoidal surgery of pituitary adenomas and other forms of pituitary pathology]. Acta Neurol (Napoli) 1981 0.75
59 Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas. J Clin Endocrinol Metab 1998 0.75
60 Acute administration of hexarelin stimulates GH secretion during day and night in normal men. Clin Endocrinol (Oxf) 1997 0.75
61 [Determination of cerebrospinal fluid beta-endorphin during trans-sphenoidal surgery Preliminary note]. Minerva Anestesiol 1986 0.75
62 Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. Eur J Endocrinol 1994 0.75
63 [Growth hormone and the heart]. Cardiologia 1993 0.75
64 New medical approaches in pituitary adenomas. Horm Res 2000 0.75
65 Impaired luteinizing hormone responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinuses of hyperprolactinemic patients. Gynecol Endocrinol 1995 0.75
66 Alpha-melanocyte-stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. Neuroendocrinology 1993 0.75
67 [Changes of lung volumes and respiratory muscle strength in patients with growth hormone deficiency]. Ann Ital Med Int 1996 0.75
68 The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J Clin Endocrinol Metab 1995 0.75
69 Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease. Clin Endocrinol (Oxf) 1996 0.75
70 Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. J Endocrinol Invest 1995 0.75
71 [G-proteins, receptor signal transduction, and growth hormone secretion]. Minerva Endocrinol 1993 0.75
72 Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration. J Endocrinol Invest 1998 0.75
73 [Trans-sphenoidal surgery of pituitary adenomas and other forms of pituitary pathology]. Acta Neurol Quad (Napoli) 1981 0.75
74 [Cardiac effects of GH]. Minerva Endocrinol 1993 0.75
75 Fixity of vocal cords and laryngocele in acromegaly. J Endocrinol Invest 1997 0.75
76 Comparison of anterior pituitary hormone levels in the inferior petrosal sinuses and peripheral blood in various pituitary disorders during perihypophysial phlebography. Acta Endocrinol (Copenh) 1991 0.75
77 [Randomized comparative study using carbocalcitonin i.m. vs carbocalcitonin nasal spray vs ipriflavone x os in the treatment of post-menopausal osteoporosis]. Minerva Endocrinol 1993 0.75